身体状况极差的老年侵袭性B细胞淋巴瘤患者可从强化化疗中获益。 - Suppr | 超能文献

Very poor performance status elderly patients with aggressive B cell lymphomas can benefit from intensive chemotherapy.

作者信息

Bowcock Stella J, Fontana Vincenzo, Patrick Hannah E

出版信息

Br J Haematol. 2012 May;157(3):391-3. doi: 10.1111/j.1365-2141.2011.08987.x. Epub 2011 Dec 22.

DOI:10.1111/j.1365-2141.2011.08987.x

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Very poor performance status elderly patients with aggressive B cell lymphomas can benefit from intensive chemotherapy.身体状况极差的老年侵袭性B细胞淋巴瘤患者可从强化化疗中获益。

Br J Haematol. 2012 May;157(3):391-3. doi: 10.1111/j.1365-2141.2011.08987.x. Epub 2011 Dec 22.

2

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.复发侵袭性淋巴瘤的治疗：含与不含高剂量治疗及干细胞救援的方案

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12.

3

Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.接受一线强化化疗和自体移植治疗的高危侵袭性淋巴瘤患者：年龄校正国际预后指数评分为2分和3分的患者之间结局存在显著差异的证据。

Cancer. 2003 Sep 1;98(5):983-92. doi: 10.1002/cncr.11610.

4

[Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].利妥昔单抗联合化疗治疗侵袭性B细胞非霍奇金淋巴瘤的临床分析

Ai Zheng. 2004 Dec;23(12):1681-6.

5

[Treatment of primary mediastinal large B-cell lymphomas].[原发性纵隔大B细胞淋巴瘤的治疗]

Orv Hetil. 2004 Dec 12;145(50):2531-7.

6

Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.T细胞非霍奇金淋巴瘤患者的预后因素及治疗：纪念斯隆凯特琳癌症中心的经验

Cancer. 2005 May 15;103(10):2091-8. doi: 10.1002/cncr.20999.

7

Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.老年弥漫性大B细胞淋巴瘤患者基于多柔比星的化疗：年轻与老年患者治疗结果比较及多柔比星剂量的意义

Cancer. 2003 Dec 15;98(12):2651-6. doi: 10.1002/cncr.11846.

8

Standard treatment of advanced-stage diffuse large B-cell lymphoma.晚期弥漫性大B细胞淋巴瘤的标准治疗方法。

Semin Hematol. 2006 Oct;43(4):213-20. doi: 10.1053/j.seminhematol.2006.07.004.

9

Rituximab for the treatment of diffuse large B-cell lymphomas.利妥昔单抗用于治疗弥漫性大B细胞淋巴瘤。

Expert Rev Anticancer Ther. 2006 Aug;6(8):1175-86. doi: 10.1586/14737140.6.8.1175.

10

Malignant lymphomas in the elderly.

Clin Geriatr Med. 1997 May;13(2):251-63.

引用本文的文献

1

Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma.在新诊断的弥漫性大 B 细胞淋巴瘤老年、脆弱患者中，前期利妥昔单抗/泼尼松治疗与衰老相关的促炎细胞因子环境。

Haematologica. 2022 May 1;107(5):1144-1152. doi: 10.3324/haematol.2021.278719.

2

A Complicated Case of Diffuse Large B-Cell Lymphoma in an Elderly Presenting with Massive Gastrointestinal Bleeding Successfully Treated with R-mini CHOP.一例老年弥漫性大B细胞淋巴瘤合并大量胃肠道出血的复杂病例经R-mini CHOP方案成功治疗

Case Rep Oncol. 2021 Mar 2;14(1):262-268. doi: 10.1159/000512826. eCollection 2021 Jan-Apr.

3

Lymphomas diagnosed in an internal medicine department compared to lymphomas diagnosed in other departments: Clinical and outcome differences.内科诊断的淋巴瘤与其他科室诊断的淋巴瘤相比：临床及预后差异

Medicine (Baltimore). 2018 Nov;97(47):e13228. doi: 10.1097/MD.0000000000013228.